Knowledge Management

Maximize knowledge management: leverage information for competitive advantage
By Conformia
White paper
This white paper by Conformia highlights a study uncovering where companies struggle as they manage information. The findings were used to design a solution roadmap to achieving visibility, productivity, traceability and timeliness.

Saving costs and increasing availability with HP, SAP and SUSE LINUX
By Hewlett-Packard Co.
Case study
In this case study, HP helps Infraserv, a site operator for pharmaceutical companies, to maximize system stability and flexibility and ensure a seamless flow of data between the company’s SAP R/3 system and a new SAP portal.

Content management streamlines government compliance for pharmaceutical company
By EMC Corp.
Case study
In this case study, EMC Corp.’s content management system streamlines the submission of new drug applications, supports documentation and cuts time to market for approved drugs for Otsuka America Pharmaceutical Co.

Price trends for frequently used brand and generic drugs, 2000-2004
By U.S. Government Accountability Office
White paper
This U.S. Government Accountability Office white paper tracked average prices charged at retail pharmacies for drugs. Its conclusion? Prescription drug spending has been the fastest-growing segment of national health expenditures.

What patent owners should consider in filing for a patent term extension
By Sterne Kessler Goldstein & Fox PLLC
White paper
This white paper by Sterne Kessler Goldstein & Fox PLLC discusses four essential points that manufacturers must be aware of with the Hatch-Waxman Act, which clarified patent extension law.

Fighting generic competition: Strategies for research-based companies
By URCH Publishing
White paper
This white paper from URCH Publishing Ltd. discusses the pros and cons of litigation and other approaches by pharma companies to protect their patent exclusivity and intellectual property in the face of patent expirations.

Market size in innovation: Theory and evidence from the pharmaceutical industry
By Massachusetts Institute of Technology
White paper
This white paper by MIT develops a simple model linking innovation to potential market size, and shows that under a variety of circumstances, greater market size for a particular product, which implies greater sales, spurs faster innovation.

Pharma 2010: The Threshold of Innovation
By IBM Corp.
White paper
This white paper is part of IBM Business Consulting Services' on-going commitment to forward-looking industry and business points of view, and their aim to help companies and industries transform futures.

Accelerating time to market for new drugs
By BroadVision Inc.
White paper
This white paper by BroadVision Inc. explores business-to-business solutions that can help pharmaceutical companies ensure effective collaboration with partners.

Challenge and opportunity on the critical path to new medical products
By FDA Center for Drug Evaluation and Research
White paper
This white paper by the FDA's Center for Drug Evaluation and Research (CDER) analyzes the pipeline problem in innovative medical therapies reaching patients and calls for a joint effort of industry, academia and the FDA to develop solutions.